trial · primary record
Nintedanib
Bronchiolitis Obliterans Syndrome (BOS)
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2026-07-29 |
| Primary endpoint | adverse event rate leading to interruption/ discontinuation of study treatment |
| Registry ID | NCT03805477 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:20.913Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03805477
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.